Work

Oc.11.4 Re-gain of Response in Crohn's Disease Adalimumab (ada) Dose-escalating Failure or Early Relapse. a Single Centre Experience

Year: 2013

Type: article

Source: Digestive and Liver Disease

DOI: 10.1016/s1590-8658(13)60220-0

Authors: C. Pratico', P. Gionchetti, G. Spuri Fornarini, A. Calafiore, M. Campieri, C. Calabrese, F. Rizzello

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1998403266

FWCI:

Cites:

Cited by:

Related to: 10